TY - JOUR
T1 - Mouse a-Defensins
T2 - Structural and Functional Analysis of the 17 Cryptdin Isoforms Identified from a Single Jejunal Crypt
AU - Wang, Qingxia
AU - Yang, Yilin
AU - Luo, Gan
AU - Zhou, Yang
AU - Tolbert, William D.
AU - Pazgier, Marzena
AU - Liao, Chongbing
AU - Lu, Wuyuan
N1 - Publisher Copyright:
Copyright © 2022 Wang et al.
PY - 2023/1
Y1 - 2023/1
N2 - Mouse a-defensins, better known as cryptdins, are host protective antimicrobial peptides produced in the intestinal crypt by Paneth cells. To date, more than 20 cryptdin mRNAs have been identified from mouse small intestine, of which the first six cryptdins (Crp1 to Crp6) have been isolated and characterized at the peptide level. We quantified bactericidal activities against Escherichia coli and Staphylococcus aureus of the 17 cryptdin isoforms identified by Ouellette and colleagues from a single jejunal crypt (A. J. Ouellette et al., Infect Immun 62:5040–5047, 1994), along with linearized analogs of Crp1, Crp4, and Crp14. In addition, we analyzed the most potent and weakest cryptdins in the panel with respect to their ability to self-associate in solution. Finally, we solved, for the first time, the high-resolution crystal structure of a cryptdin, Crp14, and performed molecular dynamics simulation on Crp14 and a hypothetical mutant, T14K-Crp14. Our results indicate that mutational effects are highly dependent on cryptdin sequence, residue position, and bacterial strain. Crp14 adopts a disulfide-stabilized, three-stranded b-sheet core structure and forms a noncanonical dimer stabilized by asymmetrical interactions between the two b1 strands in parallel. The killing of E. coli by cryptdins is generally independent of their tertiary and quaternary structures that are important for the killing of S. aureus, which is indicative of two distinct mechanisms of action. Importantly, sequence variations impact the bactericidal activity of cryptdins by influencing their ability to self-associate in solution. This study expands our current understanding of how cryptdins function at the molecular level.
AB - Mouse a-defensins, better known as cryptdins, are host protective antimicrobial peptides produced in the intestinal crypt by Paneth cells. To date, more than 20 cryptdin mRNAs have been identified from mouse small intestine, of which the first six cryptdins (Crp1 to Crp6) have been isolated and characterized at the peptide level. We quantified bactericidal activities against Escherichia coli and Staphylococcus aureus of the 17 cryptdin isoforms identified by Ouellette and colleagues from a single jejunal crypt (A. J. Ouellette et al., Infect Immun 62:5040–5047, 1994), along with linearized analogs of Crp1, Crp4, and Crp14. In addition, we analyzed the most potent and weakest cryptdins in the panel with respect to their ability to self-associate in solution. Finally, we solved, for the first time, the high-resolution crystal structure of a cryptdin, Crp14, and performed molecular dynamics simulation on Crp14 and a hypothetical mutant, T14K-Crp14. Our results indicate that mutational effects are highly dependent on cryptdin sequence, residue position, and bacterial strain. Crp14 adopts a disulfide-stabilized, three-stranded b-sheet core structure and forms a noncanonical dimer stabilized by asymmetrical interactions between the two b1 strands in parallel. The killing of E. coli by cryptdins is generally independent of their tertiary and quaternary structures that are important for the killing of S. aureus, which is indicative of two distinct mechanisms of action. Importantly, sequence variations impact the bactericidal activity of cryptdins by influencing their ability to self-associate in solution. This study expands our current understanding of how cryptdins function at the molecular level.
KW - antimicrobial peptides
KW - cryptdins
KW - defensins
KW - host defense peptides
KW - structure-function
KW - structure-to-activity
KW - virtual colony count
UR - http://www.scopus.com/inward/record.url?scp=85147048028&partnerID=8YFLogxK
U2 - 10.1128/iai.00361-22
DO - 10.1128/iai.00361-22
M3 - Article
C2 - 36472443
AN - SCOPUS:85147048028
SN - 0019-9567
VL - 91
JO - Infection and Immunity
JF - Infection and Immunity
IS - 1
ER -